Elisa Muscianisi
Vice President, Clinical Development Alumis Inc.
Executive leader with extensive experience in clinical development and medical affairs. Deep knowledge of European and US market dynamics, passionate about creating a fruitful continuum from development to post-marketing ensuring drug accessibility and unmet need coverage. Highly focused on people and culture, excels in nurturing high performing and collaborative teams. Committed, resilient, network leader and strong team player with agility to perform across different therapeutic areas.
Seminars
Thursday 21st May 2026
Panel Discussion: Modernising Dermatology Trial Design: Reducing Placebo Noise, Updating Endpoints & Strengthening Site Execution
11:30 am
- Redesigning dermatology endpoints by addressing outdated scales, high placebo response, and the need for validated assessments in understudied diseases where current tools fail to capture meaningful patient change
- Improving trial integrity through stronger site strategy by prioritising dermatology-specific expertise, rigorous site preparation, and high-quality CRO oversight to minimise variability, reduce placebo inflation, and ensure reliable clinical evaluation
- Designing studies that reflect real-world dermatology by incorporating combination therapy considerations, cultural and behavioural adaptations, patient-centred outcomes, and feasible protocols that account for Europe’s fragmented healthcare pathways
